NZ608598A - A transdermal drug administration device - Google Patents
A transdermal drug administration deviceInfo
- Publication number
- NZ608598A NZ608598A NZ60859811A NZ60859811A NZ608598A NZ 608598 A NZ608598 A NZ 608598A NZ 60859811 A NZ60859811 A NZ 60859811A NZ 60859811 A NZ60859811 A NZ 60859811A NZ 608598 A NZ608598 A NZ 608598A
- Authority
- NZ
- New Zealand
- Prior art keywords
- administration device
- drug administration
- transdermal drug
- force
- delivery element
- Prior art date
Links
- 238000001647 drug administration Methods 0.000 title abstract 2
- 238000012377 drug delivery Methods 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 239000012876 carrier material Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000011148 porous material Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medical Informatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38053910P | 2010-09-07 | 2010-09-07 | |
| PCT/GB2011/051658 WO2012032337A2 (en) | 2010-09-07 | 2011-09-05 | A transdermal drug administration device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ608598A true NZ608598A (en) | 2015-03-27 |
Family
ID=44764181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ60859811A NZ608598A (en) | 2010-09-07 | 2011-09-05 | A transdermal drug administration device |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10251834B2 (en:Method) |
| EP (1) | EP2613784B1 (en:Method) |
| JP (1) | JP5843864B2 (en:Method) |
| KR (2) | KR102084571B1 (en:Method) |
| AU (1) | AU2011300524B2 (en:Method) |
| CA (1) | CA2809927C (en:Method) |
| DK (1) | DK2613784T3 (en:Method) |
| ES (1) | ES2658913T3 (en:Method) |
| NO (1) | NO2613784T3 (en:Method) |
| NZ (1) | NZ608598A (en:Method) |
| PL (1) | PL2613784T3 (en:Method) |
| WO (1) | WO2012032337A2 (en:Method) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5691051B2 (ja) * | 2009-05-08 | 2015-04-01 | エンプリキュア・アクチエボラゲット | ジオポリマー結合剤を含む持続薬物送達用組成物 |
| CN111389345A (zh) | 2013-02-01 | 2020-07-10 | 格雷斯公司 | 作为用于液体技术的载体的多孔硅胶 |
| US9623017B2 (en) | 2014-09-24 | 2017-04-18 | Pain Therapeutics, Inc. | 4:3 naltrexone: 5-methyl-2-furaldehyde cocrystal |
| ES2750853T3 (es) * | 2014-10-14 | 2020-03-27 | Hisamitsu Pharmaceutical Co | Parche adhesivo |
| GB201503961D0 (en) * | 2015-03-09 | 2015-04-22 | Emplicure Ab | A transdermal drug administration device |
| CA3016205A1 (en) | 2016-02-29 | 2017-09-08 | Emplicure Ab | Devices for evaporation and inhalation of active agents |
| KR101719319B1 (ko) * | 2016-04-05 | 2017-03-23 | 주식회사 엘지생활건강 | 효율적인 피부 천공을 위한 마이크로니들 구조 |
| US9650338B1 (en) | 2016-07-29 | 2017-05-16 | VDM Biochemicals, Inc. | Opioid antagonist compounds and methods of making and using |
| CN106265584B (zh) * | 2016-08-31 | 2019-04-09 | 浙江工业大学 | 埃洛石纳米管为骨架的肠溶复合载药体系及其制备方法 |
| CN116873874A (zh) | 2017-04-18 | 2023-10-13 | 突破技术有限责任公司 | 硫的生产 |
| JP2021506790A (ja) * | 2017-12-14 | 2021-02-22 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 塩形態の有効成分を含むマイクロニードルアレイ |
| CN110448543A (zh) * | 2019-09-16 | 2019-11-15 | 临沂大学 | 一种基于埃洛石纳米管/壳聚糖复合骨架的绿原酸肠溶缓释微球及其制备方法 |
| IL295549A (en) * | 2020-02-13 | 2022-10-01 | Eyal Res Consultants Ltd | Microbial compositions with modulators of the opioid system and uses thereof |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989005632A1 (en) | 1983-11-14 | 1989-06-29 | The University Of Kentucky Research Foundation | Porous microspheres for drug delivery and methods for making same |
| EP0265061B1 (en) | 1986-09-18 | 1992-01-08 | London School of Pharmacy Innovations Ltd | Pharmaceutical formulation |
| IT1197316B (it) | 1986-10-01 | 1988-11-30 | Proter Spa | Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico |
| JP2702953B2 (ja) | 1988-01-30 | 1998-01-26 | オリンパス光学工業株式会社 | 薬液含浸セラミックス |
| IT1216570B (it) | 1988-04-08 | 1990-03-08 | Vectorpharma Int | Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. |
| JPH02268104A (ja) | 1989-04-07 | 1990-11-01 | Kanebo Ltd | 抗菌性組成物 |
| US5443812A (en) | 1989-04-24 | 1995-08-22 | Kanebo Ltd. | Stabilized synthetic zeolite and a process for the preparation thereof |
| JPH07188000A (ja) | 1993-12-27 | 1995-07-25 | Bridgestone Corp | 薬用被覆材 |
| JPH0930988A (ja) | 1995-07-21 | 1997-02-04 | Sumitomo Osaka Cement Co Ltd | 薬剤徐放性多孔質セラミックス成形体及びその製造方法 |
| GB2307862A (en) * | 1995-12-05 | 1997-06-11 | David Jehan | Patch structures for transdermal therapy |
| EP0947489A4 (en) | 1996-11-25 | 2001-08-08 | Advance Kk | PROCESS FOR PRODUCING CERAMICS |
| US5902591A (en) | 1997-04-03 | 1999-05-11 | La Prairie Sa | Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid |
| US6503231B1 (en) | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
| US6123925A (en) | 1998-07-27 | 2000-09-26 | Healthshield Technologies L.L.C. | Antibiotic toothpaste |
| US6635281B2 (en) | 1998-12-23 | 2003-10-21 | Alza Corporation | Gastric retaining oral liquid dosage form |
| US6342249B1 (en) | 1998-12-23 | 2002-01-29 | Alza Corporation | Controlled release liquid active agent formulation dosage forms |
| US20030118641A1 (en) | 2000-07-27 | 2003-06-26 | Roxane Laboratories, Inc. | Abuse-resistant sustained-release opioid formulation |
| AUPQ573300A0 (en) | 2000-02-21 | 2000-03-16 | Australian Nuclear Science & Technology Organisation | Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| AU2001255215A1 (en) | 2000-03-24 | 2001-10-08 | Mark B Lyles | High density porous materials |
| WO2001076598A1 (en) | 2000-04-11 | 2001-10-18 | Sankyo Company, Limited | Stabilized pharmaceutical compositions containing calcium channel blockers |
| US6602523B1 (en) | 2000-08-17 | 2003-08-05 | Technology Holding, Llc. | Composite material and process for increasing bioavailability and activity of a beneficial agent |
| US20020122828A1 (en) | 2001-03-02 | 2002-09-05 | Jun Liu | Hybrid porous materials for controlled release |
| US6767557B2 (en) | 2001-03-05 | 2004-07-27 | Ortho-Mcneil Pharmaceutical, Inc. | Taste masked pharmaceutical compositions |
| JP4393870B2 (ja) | 2001-09-24 | 2010-01-06 | ボストン サイエンティフィック リミテッド | 薬剤被覆ステントのための最適用量 |
| WO2003026687A1 (en) | 2001-09-28 | 2003-04-03 | Nutraceutix, Inc. | Delivery system for biological component |
| US20030118528A1 (en) * | 2001-11-19 | 2003-06-26 | Walters Kenneth A. | Topical delivery of codrugs |
| AU2003221752A1 (en) | 2002-04-23 | 2003-11-10 | Alza Corporation | Transdermal analgesic systems with reduced abuse potential |
| AU2003222691A1 (en) | 2002-04-30 | 2003-11-17 | Morteza Shirkhanzadeh | Arrays of microneedles comprising porous calcium phosphate coating and bioactive agents |
| WO2004024224A1 (en) | 2002-09-16 | 2004-03-25 | Sung-Yun Kwon | Solid micro-perforators and methods of use |
| SE524334C2 (sv) | 2002-09-30 | 2004-07-27 | Cerbio Tech Ab | Värmegenererande biokompatibla keramiska material och förfarande för dess framställning |
| SE525236C2 (sv) | 2002-10-31 | 2005-01-11 | Cerbio Tech Ab | Förfarande för framställning av strukturerade keramiska beläggningar och belagda anordningar framställda med detta förfarande |
| SE524494C2 (sv) | 2002-12-31 | 2004-08-17 | Doxa Ab | Kemiskt bundna biomaterialelement med skräddarsydda egenskaper |
| CN1859906A (zh) | 2003-10-15 | 2006-11-08 | 株式会社纳米卵 | 含有多价金属无机盐包覆的视黄酸纳米颗粒的组合物 |
| WO2005039508A1 (en) | 2003-10-29 | 2005-05-06 | Doxa Ab | A two-step system for improved initial and final characteristics of a biomaterial |
| US20050181049A1 (en) | 2003-11-19 | 2005-08-18 | Dong Liang C. | Composition and method for enhancing bioavailability |
| AU2004311880B2 (en) | 2003-12-31 | 2010-08-05 | Phoenix Labs Unlimited Company | Generally linear effervescent oral fentanyl dosage form and methods of administering |
| WO2005075016A1 (ja) | 2004-02-03 | 2005-08-18 | Hisamitsu Pharmaceutical Co., Inc. | 経皮薬物投与装置用インタフェース |
| US7315758B2 (en) * | 2004-06-03 | 2008-01-01 | Lynntech, Inc. | Transdermal delivery of therapeutic agent |
| KR101352299B1 (ko) | 2004-06-28 | 2014-02-17 | 벨로시스 파마슈티컬스 에이/에스 | 액상 제형용 담체로서의 다공성 정제 |
| CN101010051A (zh) | 2004-07-13 | 2007-08-01 | 爱尔达纳米公司 | 用于控释药物的陶瓷结构 |
| KR20070042176A (ko) | 2004-07-13 | 2007-04-20 | 알타이어나노 인코포레이티드 | 약물 전용의 방지를 위한 세라믹 구조체 |
| WO2006015299A2 (en) * | 2004-07-30 | 2006-02-09 | Microchips, Inc. | Multi-reservoir device for transdermal drug delivery and sensing |
| CA2577583A1 (en) | 2004-08-19 | 2006-03-02 | Alza Corporation | Controlled release nanoparticle active agent formulation dosage forms and methods |
| US8535702B2 (en) | 2005-02-01 | 2013-09-17 | Boston Scientific Scimed, Inc. | Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility |
| FR2881652B1 (fr) | 2005-02-08 | 2007-05-25 | Flamel Technologies Sa | Forme pharmaceutique orale microparticulaire anti-mesuage |
| EP1868562A1 (en) | 2005-03-04 | 2007-12-26 | Altairnano, Inc | Ceramic structures for controlled release of biologically active substances |
| DE102005040429A1 (de) | 2005-08-25 | 2007-03-01 | Heraeus Kulzer Gmbh | Wirkstofffreisetzungssystem und seine Verwendung |
| US8652529B2 (en) | 2005-11-10 | 2014-02-18 | Flamel Technologies | Anti-misuse microparticulate oral pharmaceutical form |
| US7682445B2 (en) | 2005-12-08 | 2010-03-23 | Doxa Ab | Powdered CBC system with improved reaction feature |
| EP1971351A2 (en) | 2005-12-29 | 2008-09-24 | Robert Basic | Mineral-herbal preparation consisting of zeolite and astragalus membranaceus root extract to treat allergies |
| US20080200262A1 (en) | 2006-01-20 | 2008-08-21 | David Whitby | Video game instruction card holder |
| US20070212414A1 (en) | 2006-03-08 | 2007-09-13 | Penwest Pharmaceuticals Co. | Ethanol-resistant sustained release formulations |
| US20070248656A1 (en) | 2006-04-25 | 2007-10-25 | Galer Bradley S | Topical preparation dispensers and methods of using the same |
| US9023400B2 (en) | 2006-05-24 | 2015-05-05 | Flamel Technologies | Prolonged-release multimicroparticulate oral pharmaceutical form |
| DE102006028781A1 (de) | 2006-06-23 | 2007-12-27 | Robert Bosch Gmbh | Verfahren zur Herstellung von porösen Mikronadeln und ihre Verwendung |
| US20080214987A1 (en) * | 2006-12-22 | 2008-09-04 | Nanomed Devices, Inc. | Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances |
| WO2008105737A1 (en) | 2007-03-01 | 2008-09-04 | Doxa Ab | Stable cement composition for orthopaedic and dental use |
| WO2008105739A1 (en) | 2007-03-01 | 2008-09-04 | Doxa Ab | Drug implant carrier for drug delivery |
| WO2008105738A1 (en) | 2007-03-01 | 2008-09-04 | Doxa Ab | Injectable cement composition for orthopaedic and dental use |
| WO2008118096A1 (en) | 2007-03-28 | 2008-10-02 | Doxa Ab | Carriers for drug delivery |
| CN101104080B (zh) | 2007-04-24 | 2011-06-22 | 深圳市鸿华投资有限公司 | 沸石止血敷料及其制备方法和用途 |
| GB0709541D0 (en) | 2007-05-17 | 2007-06-27 | Jagotec Ag | Pharmaceutical excipient |
| EP2100850A1 (en) | 2008-03-11 | 2009-09-16 | Stichting Voor De Technische Wetenschappen | Microneedle array and a method for manufacturing microneedles |
| EP2398577A2 (en) | 2009-02-19 | 2011-12-28 | Bonner, Alex Garfield | Porous interpenetrating polymer network |
-
2011
- 2011-09-05 WO PCT/GB2011/051658 patent/WO2012032337A2/en not_active Ceased
- 2011-09-05 DK DK11767034.9T patent/DK2613784T3/da active
- 2011-09-05 KR KR1020187003892A patent/KR102084571B1/ko not_active Expired - Fee Related
- 2011-09-05 EP EP11767034.9A patent/EP2613784B1/en active Active
- 2011-09-05 AU AU2011300524A patent/AU2011300524B2/en not_active Ceased
- 2011-09-05 NO NO11767034A patent/NO2613784T3/no unknown
- 2011-09-05 KR KR1020137008926A patent/KR20140003405A/ko not_active Ceased
- 2011-09-05 US US13/821,039 patent/US10251834B2/en active Active
- 2011-09-05 NZ NZ60859811A patent/NZ608598A/en not_active IP Right Cessation
- 2011-09-05 CA CA2809927A patent/CA2809927C/en active Active
- 2011-09-05 ES ES11767034.9T patent/ES2658913T3/es active Active
- 2011-09-05 PL PL11767034T patent/PL2613784T3/pl unknown
- 2011-09-05 JP JP2013527682A patent/JP5843864B2/ja not_active Expired - Fee Related
-
2019
- 2019-04-05 US US16/376,317 patent/US10736838B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011300524A1 (en) | 2013-02-21 |
| NO2613784T3 (en:Method) | 2018-05-12 |
| US10736838B2 (en) | 2020-08-11 |
| KR102084571B1 (ko) | 2020-03-04 |
| KR20140003405A (ko) | 2014-01-09 |
| JP5843864B2 (ja) | 2016-01-13 |
| AU2011300524B2 (en) | 2014-10-23 |
| CA2809927C (en) | 2019-08-20 |
| US20190282494A1 (en) | 2019-09-19 |
| JP2013536875A (ja) | 2013-09-26 |
| US20130273119A1 (en) | 2013-10-17 |
| ES2658913T3 (es) | 2018-03-12 |
| WO2012032337A2 (en) | 2012-03-15 |
| KR20180018840A (ko) | 2018-02-21 |
| PL2613784T3 (pl) | 2018-05-30 |
| DK2613784T3 (da) | 2018-01-29 |
| EP2613784B1 (en) | 2017-12-13 |
| CA2809927A1 (en) | 2012-03-15 |
| EP2613784A2 (en) | 2013-07-17 |
| WO2012032337A3 (en) | 2012-04-26 |
| US10251834B2 (en) | 2019-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ608598A (en) | A transdermal drug administration device | |
| MY163809A (en) | Transdermal drug delivery system containing donepezil | |
| MY149623A (en) | Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation | |
| EP2258441A3 (en) | Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs | |
| WO2009029958A3 (en) | Implantable delivery device | |
| MX2020000651A (es) | Sistema de administracion transdermica con una membrana microporosa que tiene poros llenos de solvente. | |
| IN2014DN11232A (en:Method) | ||
| MX2009012273A (es) | Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica. | |
| NZ704011A (en) | Abuse deterrent pharmaceutical compositions for controlled release | |
| WO2010042471A3 (en) | Medical devices for delivery of therapeutic agents to body lumens | |
| NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
| WO2012009684A3 (en) | Drug delivery medical device | |
| MX2021004546A (es) | Composiciones de suministro de farmaco implantables y metodos de uso de las mismas. | |
| MX356111B (es) | Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata. | |
| IN2012DN01225A (en:Method) | ||
| MX2016008138A (es) | Sistema para el suministro transdermico de ingredientes activos. | |
| AR072492A1 (es) | Dispositivo y administracion transdermica de estrogeno | |
| MY183873A (en) | Transdermal therapeutic system for application of an agent | |
| MX2015008286A (es) | Composiciones multipolimericas para liberación transdermica de farmaco. | |
| EP4238580A3 (en) | Transdermal delivery system including an interface mediator | |
| IN2014DN09817A (en:Method) | ||
| PL3655364T3 (pl) | Zastosowanie materiału nośnikowego w układzie dostarczania do uwalniania jednego lub większej liczby środków czynnych w preparacie do pielęgnacji domowej | |
| WO2008151040A3 (en) | Analgesic coated medical product | |
| BR112013010829B8 (pt) | Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação | |
| MX2023007741A (es) | Formulaciones de upadacitinib de liberacion prolongada. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2016 BY RENEWALS TEAM Effective date: 20150820 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2017 BY RENEWALS TEAM Effective date: 20160827 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2018 BY RENEWALS TEAM Effective date: 20170826 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2019 BY RENEWALS TEAM Effective date: 20180818 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2020 BY RENEWALS TEAM Effective date: 20190902 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2021 BY RENEWALS TEAM Effective date: 20200905 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2022 BY ENVOY Effective date: 20210901 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2023 BY ENVOY Effective date: 20220902 |
|
| LAPS | Patent lapsed |